99mtc-glucarate
Small moleculeexperimentalImaging agent
Clinical trial activity
1 trials · 7 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2008 (NCT00614354)
Timeline
2000s
- Jan 1, 2008
Earliest Phase 2 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 99-technetium
Oral
No
Parenteral
No
Topical
No
Also known as
- 99mtc-glucarate
- 99mtc-glucarate
- 99mtc-glucarate
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00614354 | Phase 2 | Oct 1, 2008 | Case Western Reserve University, Drexel University, Molecular Targeting Technologies, Inc., National Heart, Lung, and Blood Institute (NHLBI), University of Alabama, Birmingham, University of Pittsburgh, Yale University |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (7)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Case Western Reserve University | Academic/Hospital | 1 | 0 | 1 | 2008 |
| Drexel University | Academic/Hospital | 1 | 0 | 1 | 2008 |
| Molecular Targeting Technologies, Inc. | For profit | 1 | 1 | 1 | 2008 |
| National Heart, Lung, and Blood Institute (NHLBI) | Government | 1 | 0 | 1 | 2008 |
| University of Alabama, Birmingham | Academic/Hospital | 1 | 0 | 1 | 2008 |
| University of Pittsburgh | Academic/Hospital | 1 | 0 | 1 | 2008 |
| Yale University | Academic/Hospital | 1 | 0 | 1 | 2008 |
7 organizations
Page 1 / 1